Manjekah Dunn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manjekah Dunn has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth Emma Palmer
University of New South Wales
4 shared publications Skie Sarfaraz
School of Education, Faculty of Arts, Design & Architecture University of New South Wales Sydney Sydney New South Wales Australia
4 shared publicationsIva Strnadová
School of Education, University of New South Wales, Sydney, New South Wales, Australia
3 shared publicationsJackie Boyle
Discipline of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Medicine and Health University of New South Wales Sydney Sydney New South Wales Australia
3 shared publicationsJackie Leach Scully
Disability Innovation Institute, University of New South Wales, Sydney, New South Wales, Australia
3 shared publicationsJulie Loblinzk
School of Education, University of New South Wales, Sydney, New South Wales, Australia
3 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Wiley in Journal of Paediatrics and Child Health
Shared Decision‐Making for Genetic Tests With Children and Young People With Intellectual Disability: Considerations for Inclusive, Person‐Centred, and Respectful Approaches
With over 1000 genetic causes for neurodevelopmental conditions, genetic testing (including exome sequencing) is recommended for people with intellectual disability to guide clinical care, as well as improve empowerment, connection to peer supports, and access to funded therapies. Many genetic neurodevelopmental conditions are inherited, with a parent sharing the genetic change identified in their child. However, despite showing interest in genetic medicine, many young people and adults with intellectual disability feel excluded from full participation. There is a lack of accessible resources to support people with intellectual disability in making informed choices about genetic tests and understanding their test results. There is also little training available to healthcare professionals to help them communicate with and support young people with intellectual disability and their parents about genetics. This situation reflects a broader exclusion of people with intellectual disability from equitable and respectful access to mainstream healthcare, as highlighted in the National Roadmap to Improving the Health of People with Intellectual Disability (2021) and the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (2023). In this article, we discuss key approaches and co‐produced resources (i.e., resources created together with people with intellectual disability, academic researchers, healthcare professionals, and teachers) to equip healthcare professionals to empower children, young people, and parents with intellectual disability to make informed decisions about genetic testing and understand their test results. We highlight the need for inclusive, person‐centred, and respectful healthcare to ensure genetic medicine is equitable and accessible.
- 1 October 2025
- Published by Wiley in Journal of Paediatrics and Child Health
Open AccessShared Decision‐Making for Genetic Tests With Children and Young People With Intellectual Disability: Considerations for Inclusive, Person‐Centred, and Respectful Approaches
With over 1000 genetic causes for neurodevelopmental conditions, genetic testing (including exome sequencing) is recommended for people with intellectual disability to guide clinical care, as well as improve empowerment, connection to peer supports, and access to funded therapies. Many genetic neurodevelopmental conditions are inherited, with a parent sharing the genetic change identified in their child. However, despite showing interest in genetic medicine, many young people and adults with intellectual disability feel excluded from full participation. There is a lack of accessible resources to support people with intellectual disability in making informed choices about genetic tests and understanding their test results. There is also little training available to healthcare professionals to help them communicate with and support young people with intellectual disability and their parents about genetics. This situation reflects a broader exclusion of people with intellectual disability from equitable and respectful access to mainstream healthcare, as highlighted in the National Roadmap to Improving the Health of People with Intellectual Disability (2021) and the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (2023). In this article, we discuss key approaches and co‐produced resources (i.e., resources created together with people with intellectual disability, academic researchers, healthcare professionals, and teachers) to equip healthcare professionals to empower children, young people, and parents with intellectual disability to make informed decisions about genetic testing and understand their test results. We highlight the need for inclusive, person‐centred, and respectful healthcare to ensure genetic medicine is equitable and accessible.
- Open Access
- 9 December 2023
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (5) , 328-339
Equitable and accessible informed healthcare consent process for people with intellectual disability: a systematic literature review
Objective To identify factors acting as barriers or enablers to the process of healthcare consent for people with intellectual disability and to understand how to make this process equitable and accessible. Data sources Databases: Embase, MEDLINE, PsychINFO, PubMed, SCOPUS, Web of Science and CINAHL. Additional articles were obtained from an ancestral search and hand-searching three journals. Eligibility criteria Peer-reviewed original research about the consent process for healthcare interventions, published after 1990, involving adult participants with intellectual disability. Synthesis of results Inductive thematic analysis was used to identify factors affecting informed consent. The findings were reviewed by co-researchers with intellectual disability to ensure they reflected lived experiences, and an easy read summary was created. Results Twenty-three studies were included (1999 to 2020), with a mix of qualitative (n=14), quantitative (n=6) and mixed-methods (n=3) studies. Participant numbers ranged from 9 to 604 people (median 21) and included people with intellectual disability, health professionals, carers and support people, and others working with people with intellectual disability. Six themes were identified: (1) health professionals’ attitudes and lack of education, (2) inadequate accessible health information, (3) involvement of support people, (4) systemic constraints, (5) person-centred informed consent and (6) effective communication between health professionals and patients. Themes were barriers (themes 1, 2 and 4), enablers (themes 5 and 6) or both (theme 3). Conclusions Multiple reasons contribute to poor consent practices for people with intellectual disability in current health systems. Recommendations include addressing health professionals’ attitudes and lack of education in informed consent with clinician training, the co-production of accessible information resources and further inclusive research into informed consent for people with intellectual disability. PROSPERO registration CRD42021290548.
- 9 December 2023
- Published by BMJ in BMJ Quality & Safety
- Vol. 33 (5) , 328-339
Open AccessEquitable and accessible informed healthcare consent process for people with intellectual disability: a systematic literature review
Objective To identify factors acting as barriers or enablers to the process of healthcare consent for people with intellectual disability and to understand how to make this process equitable and accessible. Data sources Databases: Embase, MEDLINE, PsychINFO, PubMed, SCOPUS, Web of Science and CINAHL. Additional articles were obtained from an ancestral search and hand-searching three journals. Eligibility criteria Peer-reviewed original research about the consent process for healthcare interventions, published after 1990, involving adult participants with intellectual disability. Synthesis of results Inductive thematic analysis was used to identify factors affecting informed consent. The findings were reviewed by co-researchers with intellectual disability to ensure they reflected lived experiences, and an easy read summary was created. Results Twenty-three studies were included (1999 to 2020), with a mix of qualitative (n=14), quantitative (n=6) and mixed-methods (n=3) studies. Participant numbers ranged from 9 to 604 people (median 21) and included people with intellectual disability, health professionals, carers and support people, and others working with people with intellectual disability. Six themes were identified: (1) health professionals’ attitudes and lack of education, (2) inadequate accessible health information, (3) involvement of support people, (4) systemic constraints, (5) person-centred informed consent and (6) effective communication between health professionals and patients. Themes were barriers (themes 1, 2 and 4), enablers (themes 5 and 6) or both (theme 3). Conclusions Multiple reasons contribute to poor consent practices for people with intellectual disability in current health systems. Recommendations include addressing health professionals’ attitudes and lack of education in informed consent with clinician training, the co-production of accessible information resources and further inclusive research into informed consent for people with intellectual disability. PROSPERO registration CRD42021290548.
- Open Access
Exploring the Barriers and Enablers for the Equitable and Accessible Informed Healthcare Consent Process for People with Intellectual Disability: A Systematic Literature Review
Objective To identify the factors that act as barriers to, or enablers of, proper informed consent for healthcare interventions for people with intellectual disability. Design Systematic literature review. No funding sources or conflicts of interest are reported. Data sources Databases: Embase, MEDLINE, PsychINFO, PubMed, SCOPUS, Web of Science, and CINAHL (last searched January 2022). Additional articles were obtained from an ancestral search of included articles and hand-searching of three journals. Eligibility criteria Included studies must examine the informed consent process for a healthcare intervention, be published from 1990 onwards, available in English, and be original research published in a peer-reviewed journal, and participants must be adults and relevant stakeholders (including people with intellectual disability, health professionals, carers or support people, or relevant professionals). Synthesis of results Inductive thematic analysis using a six-phase method was used to identify factors affecting informed consent. The QualSyst tool was used to assess quality and biases of included studies. Results Twenty-three studies were included, published from 1999 to 2020, with a mix of qualitative (n=12), quantitative (n=6) and mixed-methods (n=4) studies. Study sizes ranged from 13 to 604 (median 23), and participants included people with intellectual disability, health professionals, carers and support people, and other professionals working with people with intellectual disability. Six themes were identified: health professionals’ attitudes towards and lack of education about informed consent, provision of health information, involvement of carers and other support people, systemic constraints, specific care needs due to patient-related factors, and effective communication between health professionals and patients. Limitations included the heterogeneity of studies, the focus on people with mild intellectual disability only, lack of reflexivity, and limited use of inclusive co-design research methods (n=5). Conclusions Health professionals’ attitudes and lack of training in informed consent for people with intellectual disability is a major barrier to proper healthcare informed consent for people with intellectual disability. The lack of accessible health information provided for people with intellectual disability also prevents proper informed consent and decision-making. Other factors are the involvement of carers and support people, inherent systemic constraints, failure to meet specific care needs of people with intellectual disability, and ineffective communication by health professionals. Further research, particularly using inclusive co-design methods, is needed to understand these factors. Practical solutions to address these barriers, such as creating accessible information resources and training health professionals, are needed to support improved proper healthcare informed consent for people with intellectual disability. Systematic review registration PROSPERO number CRD42021290548
Open AccessExploring the Barriers and Enablers for the Equitable and Accessible Informed Healthcare Consent Process for People with Intellectual Disability: A Systematic Literature Review
Objective To identify the factors that act as barriers to, or enablers of, proper informed consent for healthcare interventions for people with intellectual disability. Design Systematic literature review. No funding sources or conflicts of interest are reported. Data sources Databases: Embase, MEDLINE, PsychINFO, PubMed, SCOPUS, Web of Science, and CINAHL (last searched January 2022). Additional articles were obtained from an ancestral search of included articles and hand-searching of three journals. Eligibility criteria Included studies must examine the informed consent process for a healthcare intervention, be published from 1990 onwards, available in English, and be original research published in a peer-reviewed journal, and participants must be adults and relevant stakeholders (including people with intellectual disability, health professionals, carers or support people, or relevant professionals). Synthesis of results Inductive thematic analysis using a six-phase method was used to identify factors affecting informed consent. The QualSyst tool was used to assess quality and biases of included studies. Results Twenty-three studies were included, published from 1999 to 2020, with a mix of qualitative (n=12), quantitative (n=6) and mixed-methods (n=4) studies. Study sizes ranged from 13 to 604 (median 23), and participants included people with intellectual disability, health professionals, carers and support people, and other professionals working with people with intellectual disability. Six themes were identified: health professionals’ attitudes towards and lack of education about informed consent, provision of health information, involvement of carers and other support people, systemic constraints, specific care needs due to patient-related factors, and effective communication between health professionals and patients. Limitations included the heterogeneity of studies, the focus on people with mild intellectual disability only, lack of reflexivity, and limited use of inclusive co-design research methods (n=5). Conclusions Health professionals’ attitudes and lack of training in informed consent for people with intellectual disability is a major barrier to proper healthcare informed consent for people with intellectual disability. The lack of accessible health information provided for people with intellectual disability also prevents proper informed consent and decision-making. Other factors are the involvement of carers and support people, inherent systemic constraints, failure to meet specific care needs of people with intellectual disability, and ineffective communication by health professionals. Further research, particularly using inclusive co-design methods, is needed to understand these factors. Practical solutions to address these barriers, such as creating accessible information resources and training health professionals, are needed to support improved proper healthcare informed consent for people with intellectual disability. Systematic review registration PROSPERO number CRD42021290548
- Open Access
- 20 January 2023
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 31 (9) , 1057-1065
“I am not a number!” Opinions and preferences of people with intellectual disability about genetic healthcare
There is limited research exploring the knowledge and experiences of genetic healthcare from the perspective of people with intellectual disability. This study, conducted in New South Wales (Australia), addresses this gap. Eighteen adults with intellectual disability and eight support people were interviewed in this inclusive research study. The transcribed interviews were analysed using inductive content analysis. The findings were discussed in a focus group with ten adults with intellectual disability and in three multi-stakeholder advisory workshops, contributing to the validity and trustworthiness of the findings. Five main themes emerged: (i) access to genetic healthcare services is inequitable, with several barriers to the informed consent process; (ii) the experiences and opinions of people with intellectual disability are variable, including frustration, exclusion and fear; (iii) genetic counselling and diagnoses can be profoundly impactful, but translating a genetic diagnosis into tailored healthcare, appropriate support, peer connections and reproductive planning faces barriers; (iv) people with intellectual disability have a high incidence of exposure to trauma and some reported that their genetic healthcare experiences were associated with further trauma; (v) recommendations for a more respectful and inclusive model of genetic healthcare. Co-designed point-of-care educational and consent resources, accompanied by tailored professional education for healthcare providers, are required to improve the equity and appropriateness of genetic healthcare for people with intellectual disability.
- 20 January 2023
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 31 (9) , 1057-1065
Open Access“I am not a number!” Opinions and preferences of people with intellectual disability about genetic healthcare
There is limited research exploring the knowledge and experiences of genetic healthcare from the perspective of people with intellectual disability. This study, conducted in New South Wales (Australia), addresses this gap. Eighteen adults with intellectual disability and eight support people were interviewed in this inclusive research study. The transcribed interviews were analysed using inductive content analysis. The findings were discussed in a focus group with ten adults with intellectual disability and in three multi-stakeholder advisory workshops, contributing to the validity and trustworthiness of the findings. Five main themes emerged: (i) access to genetic healthcare services is inequitable, with several barriers to the informed consent process; (ii) the experiences and opinions of people with intellectual disability are variable, including frustration, exclusion and fear; (iii) genetic counselling and diagnoses can be profoundly impactful, but translating a genetic diagnosis into tailored healthcare, appropriate support, peer connections and reproductive planning faces barriers; (iv) people with intellectual disability have a high incidence of exposure to trauma and some reported that their genetic healthcare experiences were associated with further trauma; (v) recommendations for a more respectful and inclusive model of genetic healthcare. Co-designed point-of-care educational and consent resources, accompanied by tailored professional education for healthcare providers, are required to improve the equity and appropriateness of genetic healthcare for people with intellectual disability.
- Open Access
- 24 October 2022
- Published by Springer Nature in Research Square
“I am not a number!” Opinions and preferences of people with intellectual disability about genomic healthcare.
There is limited research exploring the knowledge and experiences of genomic healthcare from the perspective of people with intellectual disability. This study, conducted in New South Wales (Australia), addresses this gap. Eighteen adults with intellectual disability and eight support people were interviewed in this inclusive research study. The transcribed interviews were analysed using inductive content analysis. Five main themes emerged: (i) access to genomic healthcare services is inequitable, with several barriers to the informed consent process; (ii) the experiences and opinions of people with intellectual disability are variable, with some feeling frustrated, excluded and frightened; (ii) genomic counselling and diagnoses can be profoundly impactful, but many faced barriers translating a genomic diagnosis into tailored healthcare, appropriate support, peer connections and reproductive planning; (iv) people with intellectual disability have a high incidence of exposure to trauma and can find genomic healthcare emotionally triggering; (v) recommendations for a more respectful and inclusive model of genomic healthcare. Co-designed point-of-care educational and consent resources accompanied by tailored professional education for healthcare providers are required to improve the equity and appropriateness of genomic healthcare for people with intellectual disability.
- 24 October 2022
- Published by Springer Nature in Research Square
Open Access“I am not a number!” Opinions and preferences of people with intellectual disability about genomic healthcare.
There is limited research exploring the knowledge and experiences of genomic healthcare from the perspective of people with intellectual disability. This study, conducted in New South Wales (Australia), addresses this gap. Eighteen adults with intellectual disability and eight support people were interviewed in this inclusive research study. The transcribed interviews were analysed using inductive content analysis. Five main themes emerged: (i) access to genomic healthcare services is inequitable, with several barriers to the informed consent process; (ii) the experiences and opinions of people with intellectual disability are variable, with some feeling frustrated, excluded and frightened; (ii) genomic counselling and diagnoses can be profoundly impactful, but many faced barriers translating a genomic diagnosis into tailored healthcare, appropriate support, peer connections and reproductive planning; (iv) people with intellectual disability have a high incidence of exposure to trauma and can find genomic healthcare emotionally triggering; (v) recommendations for a more respectful and inclusive model of genomic healthcare. Co-designed point-of-care educational and consent resources accompanied by tailored professional education for healthcare providers are required to improve the equity and appropriateness of genomic healthcare for people with intellectual disability.